Strategic Blueprint’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,025
Closed -$357K 704
2025
Q1
$357K Sell
15,025
-141
-0.9% -$3.33K 0.02% 495
2024
Q4
$355K Buy
15,166
+4,426
+41% +$105K 0.02% 481
2024
Q3
$259K Sell
10,740
-954
-8% -$22.8K 0.02% 554
2024
Q2
$273K Sell
11,694
-58
-0.5% -$1.35K 0.02% 515
2024
Q1
$276K Sell
11,752
-50
-0.4% -$1.18K 0.02% 512
2023
Q4
$278K Buy
11,802
+73
+0.6% +$1.67K 0.02% 475
2023
Q3
$266K Buy
+11,729
New +$269K 0.02% 445
2021
Q3
Sell
-2,112
Closed -$56K 819
2021
Q2
$56K Buy
+2,112
New +$55.2K 0.01% 588

Other funds holding IBD

Strategic Blueprint's IBD Position: Q2 2025 in Review

Strategic Blueprint sold out of Inspire Corporate Bond ETF (IBD) in Q2 2025, closing a stake of 15,025 shares — an estimated $357K sold.

Strategic Blueprint first reported a position in IBD in Q2 2021 and held it in 8 quarters. The position peaked at $357K in Q1 2025. 94 funds tracked by Wall St. Rank hold IBD as of Q2 2025.

  • Strategic Blueprint reported no remaining Inspire Corporate Bond ETF position as of Q2 2025 after selling out during the quarter.
  • Strategic Blueprint sold 15,025 Inspire Corporate Bond ETF shares in Q2 2025, an estimated $357K.
  • Strategic Blueprint first reported a position in Inspire Corporate Bond ETF in Q2 2021 and held it in 8 quarters.
  • Strategic Blueprint's Inspire Corporate Bond ETF position peaked at $357K in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2025.

Based on Strategic Blueprint's 13F filing for Q2 2025, filed 30 Jul 2025.